By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Development and commercialization of innovative therapies for use in medically supervised settings-1K100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States651K100.00%